CNDT · Stage, GEX levels and seasonality

Conduent Incorporated Common Stock (CNDT)

Last close $1.25 (+0.81%) on 2026-11-13

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Open the chart

Weinstein stage

Stage 1A — Basing · 11 weeks in this stage · 30-week average $1.58

Stage 1 (basing): price moves sideways around a flattening 30-week average after a decline.

What would change it: Stage 2 begins on a weekly close above 2.01 (the base high) with price above a flat or rising 30-week SMA, ideally on at least 2× average volume.

GEX levels

Put wallGamma flipCall wall
Not set1.52

Set before the open on 2026-11-05. Members see today's levels, updated every 15 minutes. How to read GEX.

Seasonality

MonthAverage returnMonths upYears
January-10.62%0%3
February-7.23%25%4
March-11.88%25%4
April+7.37%75%4
May-3.6%25%4
June+2.51%50%4
July+2.16%75%4
August+7.52%75%4
September-0.25%50%4
October-13.3%0%4
November (this month)+0.89%67%3
December+7.76%67%3

Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.

On Signa plans

The Signa score and Action Card for CNDT, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Questions about CNDT

What Weinstein stage is CNDT in?

CNDT is in Stage 1A — Basing, for 11 weeks, based on completed weekly bars and its 30-week moving average (1.58).

How has CNDT done in November?

Over the last 3 years, CNDT averaged +0.89% in November and rose in 67% of them. Past seasonality does not predict future returns.

What are CNDT's GEX levels?

Before the open on 2026-11-05, CNDT's put wall was not set, gamma flip 1.5 and call wall 2. Signa members see today's levels, updated every 15 minutes.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.